SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a broader selloff in AI data-center and neocloud stocks, amplified by Elon Musks warning that many operators could fail or consolidate as debt financing tightens. Traders debate whether IRENs customer contracts, infrastructure and AI demand distinguish it from weaker peers, or whether capital needs and execution risks justify further concern.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broader neocloud selloff as traders react to Elon Musks warning about industry consolidation and worries that tighter credit and heavy data-center spending could leave some AI infrastructure underfunded or underutilized. The community is divided: bears see financing and execution risks, while bulls argue Nebius is better positioned than weaker peers and that the sectors demand and contracts remain strong.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is under pressure amid Elon Musks warning that debt-dependent neoclouds face failures and consolidation, amplifying concerns about the companys heavy borrowing, financing access and ability to turn AI demand into returns. Traders are divided between fears of insolvency and dilution and bullish arguments that demand, customer commitments and Nvidias backing could support the business; some also view Musks comments as self-interested.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins sharp selloff and subsequent rebound are driving attention to MSTR as a leveraged proxy for the cryptocurrency. Traders are split between bullish dip-buying and short-squeeze arguments, and bearish concerns about further Bitcoin weakness and Strategys dilution and financing risks.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Traders are focused on a sharp selloff in AI data-center and neocloud stocks after Elon Musk warned that tighter debt markets could leave many operators struggling; concerns about financing, leverage and CoreWeaves exposure add to the pressure. Some see those risks as a broader threat to APLD, while others argue its contracted data-center pipeline, insider purchases and continuing AI demand make it better positioned than smaller operators.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibres latest earnings have sparked debate: strong revenue growth was offset by declining profit and margin compression as the company invests heavily in shipping, logistics, and credit. Some traders view the selloff as an opportunity given the businesss growth, while others worry that profitability is lagging and the stocks expectations remain high.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher is drawing attention amid a steep selloff across AI data-center stocks, with traders pointing to its convertible financing and dilution alongside broader concerns about tighter debt markets and Musks warnings about weaker neocloud operators. Bulls argue CIFRs powered-shell and long-term lease model sets it apart from GPU-heavy neoclouds, while bears focus on financing, execution and selling-pressure risks.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

EWZ is drawing attention after Brazils election resultLulas unexpected win over Flvio Bolsonarosparked a sharp selloff as traders reassessed expectations for a more market-friendly outcome and worried about political and economic uncertainty. The community is split between alarm over the drop and dip-buyers who view the reaction as excessive.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Lulas runoff victory has challenged the Bolsonaro-election trade and raised concerns about political uncertainty and possible pressure on Petrobrass dividends. Traders are split between viewing the selloff as a buying opportunity given the companys low-cost oil production and seeing government intervention as a risk.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs sharp selloff and prolonged run of red sessions dominate discussion, with traders citing weakness across Bitcoin miners, concerns about Bitcoin-linked profitability and financing costs, and frustration that the AI/HPC pivot has yet to produce signed tenant leases. Sentiment is split between expectations of further losses, including around the upcoming earnings report, and dip-buyers who see the stock as oversold and due for a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Decoy Therapeutics Reports Preclinical Data For Weekly Intranasal DCOY-CoV

(RTTNews) - Tuesday, Decoy Therapeutics (DCOY) said preclinical pharmacokinetic data support once-weekly intranasal dosing of its lead program DCOY-CoV, designed to protect against endemic human coronaviruses...

Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program

Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV ProgramPR NewswireCAMBRIDGE, Mass., Sept. 29, 2026 Once-Weekly Intranasal Potential...

Catalysts Keeping Momentum Going

Today’s tape is driven by catalysts; from a proposed balance-sheet reset at Beneficient (NASDAQ:BENF) to others for Wheeler REIT (NASDAQ:WHLR), Decoy Therapeutics (NASDAQ:DCOY), Greenland Mines Ltd. (NASDAQ:GRML), NeOnc Technologies Holdings (NASDAQ:NTHI), Professional Diversity Network (NASDAQ:IPDN), and Maison Solutions (NASDAQ:MSS).

Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release

Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press ReleasePR NewswireHOUSTON, Sept. 22, 2026 HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY)(the...

Stocks Riding Compelling Catalysts

Among the listings positioned for strong sessions are Rain Enhancement Technologies (NASDAQ:RAIN), Butterfly Network (NYSE:BFLY), NeOnc Technologies Holdings (NASDAQ:NTHI), Surgery Partners (NASDAQ:SGRY), Omeros (NASDAQ:OMER), Ginkgo Bioworks (NYSE:DNA), and bioAffinity (NASDAQ:BIAF). Meanwhile, Decoy Therapeutics (NASDAQ:DCOY), Filana Therapeutics (NASDAQ:FLNA), Jaguar Health (NASDAQ:JAGX), Maze Therapeutics (NASDAQ:MAZE), Viking Therapeutics (NASDAQ:VKTX), Greenland Mines (NASDAQ:GRML), and Lianhe Sowell International (NASDAQ:LHSW) remain squarely on the market's high-catalyst radar.

Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules

Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq RulesPR...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

Decoy Therapeutics (NASDAQ:DCOY) shares rose 84.0% to $4.71 during Tuesday's pre-market session. The company's market cap stands at $1.6 million.
Greenland Mines (NASDAQ:GRML) shares rose 39.21% toread more...

Ebola Surprise Puts Decoy’s AI Antiviral Platform on a Much Bigger Stage

Decoy Therapeutics (NASDAQ:DCOY) is suddenly talking about viruses far beyond the respiratory diseases at the center of its original development strategy, as an unexpected laboratory result could open an entirely new biodefense opportunity.

Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding

Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive FundingPR NewswireCAMBRIDGE, Mass., Sept. 22, 2026 Next-Generation D-MAVs Demonstrate Potent In...

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform PR Newswire CAMBRIDGE, Mass., Aug. 3, 2026 Portfolio now...

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

Decoy Therapeutics Inc.

DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>The company has received $3.5 million from an unnamed institutional investor through a private placement.</li><li>Additional funding can be secured from the investor if certain milestones are achieved.</li><li>Decoy is currently working on a nasal-based therapy that can cure all kinds of coronaviruses and a “tripledemic” vaccine that can protect against flu, coronaviruses, and respiratory syncytial viruses.</li></ul><p>Shares of Decoy Therapeutics (DCOY) soared on Monday after the company secured up to $21 million to fund clinical trials of its lead programs targeting respiratory viral illnesses.</p><p>At the time of writing, DCOY stock was up more than 84%.</p><h2 class="st-heading-2"><strong>DCOY Secures Milestone-Based Funding</strong></h2><p>According to an SEC filing, the company has secured funding from an unnamed institutional investor through a private placement offering, under which Decoy sold 592,217 shares at $5.97 per share, raising $3.5 million.</p><p>The investor was also issued milestone-based Series A, Series B, and Series C common warrants, exercisable upon the company's achievement of certain targets. Proceeds from warrant redemptions would be an additional $17.5 million.</p><h2 class="st-heading-2"><strong>What Milestones Is DCOY Targeting?</strong></h2><p>The company will be able to receive an additional $3.5 million in funding from Series A warrants, when exercised, once it applies to begin Phase 1 trials in Europe. It will receive $7 million from Series B warrants once the U.K. health regulator greenlights its Phase 2a human challenge trial, and another $7 million from Series C warrants if the early-stage U.K. trial is successful.</p><p>According to the company, it is focused on Designable Multi-Antivirals (D-MAVs), which aim to enable a single drug to work against multiple viral threats, to evolve from the traditional one-virus, one-drug model.</p><p>Decoy is currently working on a nasal-based therapy that can cure all kinds of coronaviruses and a “tripledemic” vaccine that can protect against flu, coronaviruses, and respiratory syncytial viruses.</p><h2 class="st-heading-2"><strong>What Do Retail Traders Think About DCOY?</strong></h2><p>On Stocktwits, retail sentiment on DCOY turned ‘extremely bullish’ from ‘neutral’ over the last 24 hours.</p><p><a href="https://stocktwits.com/symbol/DCOY">DCOY stock</a> has declined more than 29% so far this year and more than 91% over the last 12 months, underperforming the S&amp;P 500.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

Rising stock market chart on a trading board background. (Source: Getty Images)

Shares of Decoy Therapeutics (DCOY) soared on Monday after the company secured up to $21 million to fund clinical trials of its lead programs targeting respiratory viral illnesses.

Decoy Therapeutics has secured funding to begin clinical trials for its programs targeting respiratory illnesses.


Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.97
Prev Close	$1.03
Open	$1.03
Dividend Yield	0.00%
50-Day Moving Average	$2.40
Beta	0.23
Avg. Volume	6.47M
PE Ratio	-0.02

52-Week High	$47.64
52-Week Low	$0.96
Market Capitalization	$2.31M
EPS (Annual)	-$129.10
Price to Book	0.12
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

DCOY Fundamentals